Accuray Inc

Most Recent

  • uploads///recommendation
    Company & Industry Overviews

    Discussing Analysts’ Latest Recommendations on VAR Stock

    Varian Medical Systems (VAR) is a better-aligned, leaner business with a strong market position after the spin-off of Varex Imaging (VREX) in January 2017.

    By Sarah Collins
  • uploads///HALCYON
    Company & Industry Overviews

    Varian’s Halcyon Reaches Milestone Achievements

    Halcyon is the company’s new treatment platform for cancer patients that visually enhances and simplifies image-guided radiotherapy treatments (or IMRT).

    By Sarah Collins
  • uploads///ONCOLOGY NEEDS GROWING OUTSIDE US AND EU
    Company & Industry Overviews

    Varian’s Oncology Business Grows in Emerging Markets

    Geographic footprint Varian Medical Systems’ (VAR) oncology business reaches around the globe. With a market share of ~60%, It is a leading player in the space. Other major medical device companies in the oncology technology space include Accuray (ARAY), Boston Scientific (BSX), and GE Healthcare, a subsidiary of General Electric (GE). While~50% of the company’s oncology revenue […]

    By Sarah Collins
  • uploads///HALCYON
    Company & Industry Overviews

    Varian’s Halcyon Treatment System Sees Emerging Market Demand

    Halcyon The Halcyon system, Varian Medical Systems’ (VAR) recently launched cancer treatment device, aims to simplify and enhance IMRT (image-guided volumetric intensity modulated radiotherapy). The device has received clearance by the FDA (US Food and Drug Administration). By next year, Varian expects to receive regulatory approvals for the device in China and Japan. For more information […]

    By Sarah Collins
  • uploads///ONCOLOGY GROWTH DRIVERS
    Company & Industry Overviews

    Eclipse System Expands Varian’s Market Presence in Australia

    On December 12, Varian announced that the Peter MacCallum Cancer Centre in Melbourne had selected its Eclipse treatment planning system for the replacement of its existing platform.

    By Sarah Collins
  • uploads///recommendations
    Earnings Report

    Analyst Recommendations for Varian Medical Systems before 1Q18

    Varian Medical Systems (VAR) will announce its 1Q18 earnings results on January 24, 2018. It wants to establish itself as the leading cancer management company in the world.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    How Has Varian Medical Systems Stock Been Performing Recently?

    On December 22, Varian Medical Systems closed the trading day at a price of $110.9. The stock closed 0.18% higher on the day compared to the previous day’s close.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Varian Medical Systems’ Recent Stock Performance

    Stock performance Varian Medical Systems (VAR) closed at $96.20 on August 9, 2017. It has a 50-day moving average of $102.30, and a 200-day moving average of $93.20. On August 9, 2017, Varian stock was trading ~27% above its 52-week low of $75.90 on November 9, 2016, and ~10% below its 52-week high of $107.10 on […]

    By Sarah Collins
  • uploads///GUIDANCE
    Company & Industry Overviews

    Varian’s Long-Term Growth Strategy: Will It Drive 2018 Guidance?

    Varian Medical Systems expects to see fiscal 2018 revenue growth in the range of 2%–4%. Its adjusted diluted EPS (earnings per share) for fiscal 2018 is expected to be $4.20–$4.32.

    By Sarah Collins
  • uploads///VAR
    Company & Industry Overviews

    Here’s What Varian Medical Systems’ Valuation Trend Indicates

    Of the nine analysts covering Varian Medical Systems (VAR) stock, three have given it a “strong buy,” three have given it a “hold,” and three have given it a “sell.”

    By Kenneth Smith
  • uploads///ARAY revenue
    Company & Industry Overviews

    A Look at Accuray’s Therapy Systems

    Accuray’s Tomo therapy systems are versatile radiation therapy systems that are used for treating a wide range of cancer types.

    By Kenneth Smith
  • uploads///SIRTEX
    Company & Industry Overviews

    Sirtex Medical: Varian Medical Systems’ Latest Acquisition

    Sirtex Medical Systems is an Australia-based life sciences company with a presence around the globe. The company is focused on interventional oncology therapies.

    By Sarah Collins
  • uploads///procedure trend
    Earnings Report

    Intuitive Surgical’s Da Vinci Procedure Could Boost 2017 Results

    According to Intuitive Surgical’s (ISRG) preliminary 4Q17 and 2017 results posted by the company on January 10, 2018, it expects to post da Vinci procedure growth of 17% in 4Q17.

    By Sarah Collins
  • uploads///analyst recommendations
    Company & Industry Overviews

    Varian’s Latest Wall Street Recommendations: Mostly ‘Hold’

    According to a recent Reuters survey, which included eight investment brokerage firms, six (or 75%) of them have recommended a “hold” for VAR stock.

    By Sarah Collins
  • uploads///objectives
    Company & Industry Overviews

    A Look at Varian Medical Systems’ Long-Term Objectives

    Varian Medical Systems (VAR) spun off its imaging components business into Varex Imaging in January 2017, thus strengthening its positioning in the oncology market.

    By Sarah Collins
  • uploads///HALCYON
    Company & Industry Overviews

    Varian’s Halcyon System Sees Strong Global Growth Momentum

    Varian Medical Systems (VAR) received FDA (U.S. Food & Drug Administration) approval in June 2017 for its Halcyon system.

    By Sarah Collins
  • uploads///ONCOLOGY GROWTH DRIVERS
    Company & Industry Overviews

    How Varian Medical Systems Is Advancing Cancer Care

    Varian Medical Systems (VAR) is the leading radiation oncology technology and solutions company.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    Why Most Analysts Recommend a ‘Buy’ for Varian Medical Systems

    With its recent spin-off of Varex Imaging (VREX), Varian Medical Systems (VAR) has established itself as a focused cancer management medical technology company.

    By Sarah Collins
  • uploads///margin
    Company & Industry Overviews

    How Can BSX Improve Its Profitability Going Forward?

    In 2Q17, Boston Scientific registered a gross profit margin of 72.8% of its total sales. That compares to 70.7% in 2Q16.

    By Sarah Collins
  • uploads///projections
    Company & Industry Overviews

    What Drove Varian to Revise Its Revenue Guidance

    Company guidance Year-over-year, Varian Medical Systems (VAR) expects its 4Q17 revenue to be flat or fall. According to the company, headwinds from the euro, British pound, and Japanese yen are expected to have an impact of around $10 million, $12 million, and $15 million, respectively. The company’s diluted EPS (earnings per share) are expected to be […]

    By Sarah Collins
  • uploads///profitability drivers
    Company & Industry Overviews

    Why Varian Medical Systems’ Profitability Is Improving

    Varian Medical Systems’ profitability In 3Q17, Varian Medical Systems reported a gross margin of approximately 44.5%, representing an 18-basis-point improvement in the quarter. YTD (year-to-date), the margin has improved by around 138 basis points. In 3Q17, the company’s Oncology Systems business witnessed a gross margin improvement of 200 basis points to reach 48.1% of the segment’s total […]

    By Sarah Collins
  • uploads///long term growth
    Company & Industry Overviews

    A Look at Varian Medical Systems’ Long-Term Goals

    Varian Medical Systems’ long-term goals Varian Medical Systems (VAR) hopes to improve the lives of around 6 million cancer patients each year, which would double what the company has achieved to date. Varian is aiming for 5%–6% annual revenue growth, whereas its current 12-month trailing revenue growth is 3%. Varian aims to achieve a 22% return […]

    By Sarah Collins
  • uploads///analyst recommendations
    Company & Industry Overviews

    Analysts’ Recommendations for Varian Medical Systems

    With the spin-off of its Imaging Components business, Varian Medical Systems (VAR) is now more aligned with its core capabilities. In this series, we’ll discuss the company’s dynamics after the Varex spin-off.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Varian Medical Systems: Analyzing Its Stock Performance

    Varian Medical Systems (VAR) was trading at $102.7 on June 29, 2017. It has a 50-day moving average of $100.4 and a 200-day moving average of $88.8.

    By Sarah Collins
  • uploads///PERFORMANCE
    Company & Industry Overviews

    Varian Medical Systems Attempts to Improve Its Performance Growth

    Varian Medical Systems (VAR) raised its guidance for fiscal 2016 in the view of higher-than-expected 3Q16 results reported on July 27.

    By Sarah Collins
  • uploads///product innovation
    Company & Industry Overviews

    How Has Varian Medical Systems Progressed in Radiotherapy?

    Varian Medical Systems (VAR) has an innovation-led product pipeline.

    By Sarah Collins
  • uploads///analyst recommendations
    Company & Industry Overviews

    What Do Analysts Recommend for Varian Medical Systems?

    On June 28, 2016, Goldman Sachs gave Varian Medical Systems a one-year target price of $73, the lowest of all the target prices provided.

    By Sarah Collins
  • uploads///imaginng components market growth
    Company & Industry Overviews

    What Are the Drivers in the Global Medical Imaging Market?

    Varian Medical Systems is a global leader in the imaging components market.

    By Sarah Collins
  • uploads///radiotherapy gaps
    Company & Industry Overviews

    How Varian Is Addressing Existing Gaps in Cancer Treatment

    Varian Medical Systems has a large number of initiatives to leverage the expansion opportunities in the oncology market.

    By Sarah Collins
  • uploads///growth strategy
    Company & Industry Overviews

    Growth Strategies Driving Varian Medical Systems’ Revenue

    Varian Medical Systems has ventured into the proton therapy business and has a huge product pipeline in this area. The company generated approximately $300 million through its proton therapy business in 2015.

    By Sarah Collins
  • uploads///radiotherapy gaps
    Company & Industry Overviews

    Varian Medical Systems’ Growth Potential in Radiation Oncology

    Varian Medical Systems’ next big technology innovation will be high-definition radiotherapy, which is an intelligent treatment delivery system that aims to achieve 100% radiation exposure for the tumor.

    By Sarah Collins
  • uploads///business profile
    Company & Industry Overviews

    Varian Medical Systems: A Leading Oncology Device Manufacturer

    Varian Medical Systems (VAR), headquartered in Palo Alto, California, is a leading radiation oncology treatment device and software manufacturer. It reported revenues of approximately $3.1 billion in 2015.

    By Sarah Collins
  • uploads///business segments
    Company & Industry Overviews

    Where Does Varian Medical Systems Get Most of Its Revenue?

    Varian Medical Systems’ Imaging Components segment accounts for approximately 19% of the company’s total revenue. The segment reported a revenue decline of ~10% in 2015.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.